Association of MicroRNA Biogenesis Genes Polymorphisms with Ischemic Stroke Susceptibility and Post-Stroke Mortality
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background and Purpose MicroRNA (miRNA) expression has been examined in multiple conditions, including various cancers, neurological diseases, and cerebrovascular diseases, particularly stroke. Existing evidence indicates that miRNA biosynthesis and function play crucial roles in ischemic stroke physiology and pathology. In this study, we selected six known polymorphisms in miRNAbiogenesis genes; DICER rs13078A>T, rs3742330A>G; DROSHA rs10719T>C, rs6877842G>C; Ran GTPase (RAN) rs14035C>T; exportin 5 (XPO5) rs11077A>C. Methods We analyzed the associations between these polymorphisms and disease status and clinical factors in 585 ischemic stroke patients and 403 controls. Genotyping was performed with the polymerase chain reaction-restriction fragment length polymorphism method. Results The DICER rs3742330A>G (AA vs. AG+GG: adjusted odds ratio [AOR], 1.360; 95% confidence interval [CI], 1.024 to 1.807; P=0.034) and DROSHA rs10719T>C polymorphisms (TT vs.CC: AOR, 2.038; 95% CI, 1.113 to 3.730; P=0.021) were associated with ischemic stroke prevalence. During a mean follow-up of 4.80±2.11 years, 99 (5.91%) of the stroke patients died. In multivariate Cox proportional hazard regression models, a significant association was found between RAN rs14035 and survival of large artery disease patients with ischemic stroke (CC vs. TT: adjusted hazard ratio, 5.978; P=0.015). Conclusions An association was identified between the DICER and DROSHA polymorphisms and ischemic stroke. Specifically, polymorphisms (rs3742330 and rs10719) were more common in stroke patients, suggesting that they may be associated with an increased risk of ischemic stroke.
Abstract
Background and Purpose MicroRNA (miRNA) expression has been examined in multiple conditions, including various cancers, neurological diseases, and cerebrovascular diseases, particularly stroke. Existing evidence indicates that miRNA biosynthesis and function play crucial roles in ischemic stroke physiology and pathology. In this study, we selected six known polymorphisms in miRNAbiogenesis genes; DICER rs13078A>T, rs3742330A>G; DROSHA rs10719T>C, rs6877842G>C; Ran GTPase (RAN) rs14035C>T; exportin 5 (XPO5) rs11077A>C. Methods We analyzed the associations between these polymorphisms and disease status and clinical factors in 585 ischemic stroke patients and 403 controls. Genotyping was performed with the polymerase chain reaction-restriction fragment length polymorphism method. Results The DICER rs3742330A>G (AA vs. AG+GG: adjusted odds ratio [AOR], 1.360; 95% confidence interval [CI], 1.024 to 1.807; P=0.034) and DROSHA rs10719T>C polymorphisms (TT vs.CC: AOR, 2.038; 95% CI, 1.113 to 3.730; P=0.021) were associated with ischemic stroke prevalence. During a mean follow-up of 4.80±2.11 years, 99 (5.91%) of the stroke patients died. In multivariate Cox proportional hazard regression models, a significant association was found between RAN rs14035 and survival of large artery disease patients with ischemic stroke (CC vs. TT: adjusted hazard ratio, 5.978; P=0.015). Conclusions An association was identified between the DICER and DROSHA polymorphisms and ischemic stroke. Specifically, polymorphisms (rs3742330 and rs10719) were more common in stroke patients, suggesting that they may be associated with an increased risk of ischemic stroke.
참고문헌 (62)
- Kluijtmans LA, "Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults", Blood, 101, pp.2483~2488 (2003)[DOI]
- Gellekink H, "Genetic determinants of plasma total homocysteine", Semin Vasc Med, 5, pp.98~109 (2005)[DOI]
- Kitamura A, "High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men", Circulation, 89, pp.2533~2539 (1994)[DOI]
- Iso H, "Serum triglycerides and risk of coronary heart disease among Japanese men and women", Am J Epidemiol, 153, pp.490~499 (2001)[DOI]
- Kosch A, "Increased fasting total homocysteine plasma levels as a risk factor for thromboembolism in children", Thromb Haemost, 91, pp.308~314 (2004)
- Lee R, "Hyperhomocysteinemia and thrombosis", Hematol Oncol Clin North Am, 17, pp.85~102 (2003)[DOI]
- Ambros V, "The functions of animal microRNAs", Nature, 431, pp.350~355 (2004)[DOI]
- 고양석, "miRNA-105 and -128 function as rheostats modulating MMP-2 activities by downregulation of TIMP-2 and upregulation of MT1-MMP", Genes & Genomics, 38(2), pp.217~223 (2016), 한국유전학회[DOI]
- 백광희, "The seed sequence is necessary but insufficient for downregulation of target genes by miR-608", Genes & Genomics, 38(6), pp.567~572 (2016), 한국유전학회[DOI]
- Chen K, "The evolution of gene regulation by transcription factors and microRNAs", Nat Rev Genet, 8, pp.93~103 (2007)
- Bartel DP, "MicroRNAs: genomics, biogenesis, mechanism, and function", Cell, 116, pp.281~297 (2004)[DOI]
- Guarnieri DJ, "MicroRNAs: a new class of gene regulators", Ann Med, 40, pp.197~208 (2008)[DOI]
- Carthew RW, "Origins and mechanisms of miRNAs and siRNAs", Cell, 136, pp.642~655 (2009)[DOI]
- Nicoloso MS, "MicroRNA involvement in brain tumors: from bench to bedside", Brain Pathol, 18, pp.122~129 (2008)[DOI]
- Lu J, "MicroRNA expression profiles classify human cancers", Nature, 435, pp.834~838 (2005)[DOI]
- Hill JM, "Pathogenic microRNAs common to brain and retinal degeneration: recent observations in Alzheimer's disease and age-related macular degeneration", Front Neurol, 6, pp.232~ (2015)
- Kim J, "A microRNA feedback circuit in midbrain dopamine neurons", Science, 317, pp.1220~1224 (2007)[DOI]
- Beveridge NJ, "Dysregulation of miRNA 181b in the temporal cortex in schizophrenia", Hum Mol Genet, 17, pp.1156~1168 (2008)[DOI]
- Seyed Esmaeil Khoshnam, "Emerging Roles of microRNAs in Ischemic Stroke: As Possible Therapeutic Agents", 대한뇌졸중영문학회지, 19(2), pp.166~187 (2017), 대한뇌졸중학회[DOI]
- Jeyaseelan K, "MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion", Stroke, 39, pp.959~966 (2008)[DOI]
- Dharap A, "Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome", J Cereb Blood Flow Metab, 29, pp.675~687 (2009)[DOI]
- Bazan HA, "Acute loss of miR-221 and miR-222 in the atherosclerotic plaque shoulder accompanies plaque rupture", Stroke, 46, pp.3285~3287 (2015)[DOI]
- McManus DD, "MicroRNAs in platelet function and cardiovascular disease", Nat Rev Cardiol, 12, pp.711~717 (2015)[DOI]
- Ksiazek-Winiarek DJ, "MicroRNAs as novel regulators of neuroinflammation", Mediators Inflamm, 2013, pp.172351~ (2013)
- Zamore PD, "Ribo-gnome: the big world of small RNAs", Science, 309, pp.1519~1524 (2005)[DOI]
- Lund E, "Nuclear export of microRNA precursors", Science, 303, pp.95~98 (2004)[DOI]
- Bartel DP, "Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs", Nat Rev Genet, 5, pp.396~400 (2004)
- Kim OJ, "Association between VEGF polymorphisms and homocysteine levels in patients with ischemic stroke and silent brain infarction", Stroke, 42, pp.2393~2402 (2011)[DOI]
- Jeon YJ, "Association of the miR-146a, miR-149, miR-196a2, and miR-499 polymorphisms with ischemic stroke and silent brain infarction risk", Arterioscler Thromb Vasc Biol, 33, pp.420~430 (2013)[DOI]
- Poliseno L, "MicroRNAs modulate the angiogenic properties of HUVECs", Blood, 108, pp.3068~3071 (2006)[DOI]
- Kuehbacher A, "Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis", Circ Res, 101, pp.59~68 (2007)[DOI]
- Saxena A, "miRNA-processing enzyme Dicer is necessary for cardiac outflow tract alignment and chamber septation", Proc Natl Acad Sci U S A, 107, pp.87~91 (2010)[DOI]
- Saeki M, "DICER and DROSHA gene expression and polymorphisms in autoimmune thyroid diseases", Autoimmunity, 49, pp.514~522 (2016)[DOI]
- Rotunno M, "Inherited polymorphisms in the RNA-mediated interference machinery affect microRNA expression and lung cancer survival", Br J Cancer, 103, pp.1870~1874 (2010)[DOI]
- Zhang Y, "rs10719 polymorphism located within DROSHA 3'-untranslated region is responsible for development of primary hypertension by disrupting binding with microRNA-27b", Med Sci Monit, 23, pp.911~918 (2017)[DOI]
- Sung H, "Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case-control study in Korea", Breast Cancer Res Treat, 130, pp.939~951 (2011)[DOI]
- Albinsson S, "MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function", Arterioscler Thromb Vasc Biol, 30, pp.1118~1126 (2010)[DOI]
- Yang WJ, "Dicer is required for embryonic angiogenesis during mouse development", J Biol Chem, 280, pp.9330~9335 (2005)[DOI]
- Ungvari Z, "Aging-induced dysregulation of dicer1-dependent microRNA expression impairs angiogenic capacity of rat cerebromicrovascular endothelial cells", J Gerontol A Biol Sci Med Sci, 68, pp.877~891 (2013)[DOI]
- Asada S, "Downregulation of Dicer expression by serum withdrawal sensitizes human endothelial cells to apoptosis", Am J Physiol Heart Circ Physiol, 295, pp.H2512~H2521 (2008)[DOI]
- Suarez Y, "Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis", Proc Natl Acad Sci U S A, 105, pp.14082~14087 (2008)[DOI]
- Suarez Y, "Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells", Circ Res, 100, pp.1164~1173 (2007)[DOI]
- Lin J, "Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma", Carcinogenesis, 31, pp.1805~1812 (2010)[DOI]
- Fan P, "miRNA biogenesis enzyme Drosha is required for vascular smooth muscle cell survival", PLoS One, 8, pp.e60888~ (2013)[DOI]
- Li X, "Variation in dicer gene is associated with increased survival in T-cell lymphoma", PLoS One, 7, pp.e51640~ (2012)[DOI]
- Clague J, "Genetic variation in MicroRNA genes and risk of oral premalignant lesions", Mol Carcinog, 49, pp.183~189 (2010)
- Merritt WM, "The dicey role of Dicer: implications for RNAi therapy", Cancer Res, 70, pp.2571~2574 (2010)[DOI]
- Ma H, "Genetic variations in key microRNA processing genes and risk of head and neck cancer: a case-control study in Chinese population", PLoS One, 7, pp.e47544~ (2012)[DOI]
- Khan S, "MicroRNA related polymorphisms and breast cancer risk", PLoS One, 9, pp.e109973~ (2014)[DOI]
- Stupack DG, "Apoptotic cues from the extracellular matrix: regulators of angiogenesis", Oncogene, 22, pp.9022~9029 (2003)[DOI]
- Kertesz M, "The role of site accessibility in microRNA target recognition", Nat Genet, 39, pp.1278~1284 (2007)[DOI]
- Martin-Guerrero I, "Genetic variants in miRNA processing genes and pre-miRNAs are associated with the risk of chronic lymphocytic leukemia", PLoS One, 10, pp.e0118905~ (2015)[DOI]
- Ben-Yosef Y, "Hypoxia of endothelial cells leads to MMP-2-dependent survival and death", Am J Physiol Cell Physiol, 289, pp.C1321~C1331 (2005)[DOI]
- Calin GA, "Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia", Proc Natl Acad Sci U S A, 99, pp.15524~15529 (2002)[DOI]
- Havens MA, "Biogenesis of mammalian microRNAs by a non-canonical processing pathway", Nucleic Acids Res, 40, pp.4626~4640 (2012)[DOI]
- Sibley CR, "The biogenesis and characterization of mammalian microRNAs of mirtron origin", Nucleic Acids Res, 40, pp.438~448 (2012)[DOI]
- Dai L, "Cytoplasmic Drosha activity generated by alternative splicing", Nucleic Acids Res, 44, pp.10454~10466 (2016)
- Liu YP, "Titers of lentiviral vectors encoding shRNAs and miRNAs are reduced by different mechanisms that require distinct repair strategies", RNA, 16, pp.1328~1339 (2010)[DOI]
- Pauley KM, "Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients", Arthritis Res Ther, 10, pp.R101~ (2008)[DOI]
- Du C, "MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis", Nat Immunol, 10, pp.1252~1259 (2009)[DOI]
- O'Connell RM, "Physiological and pathological roles for microRNAs in the immune system", Nat Rev Immunol, 10, pp.111~122 (2010)[DOI]
- Liu DZ, "Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures", J Cereb Blood Flow Metab, 30, pp.92~101 (2010)[DOI]
